Showing results (71-80 of 82) with videos related to

Sort By:
Pageof 9
Circulation|January 11, 2000
Randomized comparison of elective stent implantation and coronary balloon angioplasty guided by online quantitative angiography and intracoronary Doppler. DESTINI Study Group (Doppler Endpoint STenting INternational Investigation)C Di Mario, J W Moses, T J Anderson, et al.
European Heart Journal|January 29, 2002
Impact of final coronary flow velocity reserve on late outcome following stent implantationT Nishida, C Di Mario, M J Kern, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|August 10, 2000
A randomized study of direct coronary stent delivery compared with stenting after predilatation: the NIR future trial. On behalf of the NIR Future Trial InvestigatorsJ A Ormiston, M W Webster, P N Ruygrok, et al.
Leukemia|December 21, 2007
Comparison of hypoplastic myelodysplastic syndrome (MDS) with normo-/hypercellular MDS by International Prognostic Scoring System, cytogenetic and genetic studiesT-C Huang, B-S Ko, J-L Tang, et al.
Bone Marrow Transplantation|October 7, 2008
Poor outcome in post transplant lymphoproliferative disorder with pulmonary involvement after allogeneic hematopoietic SCT: 13 years' experience in a single instituteH-A Hou, M Yao, J-L Tang, et al.
Leukemia|February 20, 2009
Acute myeloid leukemia bearing t(7;11)(p15;p15) is a distinct cytogenetic entity with poor outcome and a distinct mutation profile: comparative analysis of 493 adult patientsW-C Chou, C-Y Chen, H-A Hou, et al.
British Journal of Cancer|September 1, 2011
High bone marrow angiopoietin-1 expression is an independent poor prognostic factor for survival in patients with myelodysplastic syndromesC-L Cheng, H-A Hou, J-Y Jhuang, et al.
Leukemia|November 17, 2010
The prognostic impact and stability of Isocitrate dehydrogenase 2 mutation in adult patients with acute myeloid leukemiaW-C Chou, W-C Lei, B-S Ko, et al.
Blood Cancer Journal|August 1, 2015
TP53 mutations in de novo acute myeloid leukemia patients: longitudinal follow-ups show the mutation is stable during disease evolutionH-A Hou, W-C Chou, Y-Y Kuo, et al.
Leukemia|April 9, 2016
Genetic alterations and their clinical implications in older patients with acute myeloid leukemiaC-H Tsai, H-A Hou, J-L Tang, et al.
Pageof 9